A discussion is open on the major aspects of education and training in clinical chemistry in Europe reviewing FESCC organisations, activities and future plans and to conclude with lessons from the experiences.
FESCC is the European branch of IFCC and contains 35 countries according to WHO. FESCC is a Forum (Federation) of the national societies, which are concerned with clinical chemistry, and which are members of IFCC. IFCC (International Federation of clinical chemistry and laboratory medicine) is the world organisation of clinical chemistry and is subdivided in 4 regions Asia, Arabia, Europe and Latin America. Between FESCC and IFCC there is a direct link via the different divisions as conference and congress divisions, the scientific and education and management divisions and the communication and publication division. The FESCC vision statement should provide European leadership in clinical chemistry and clinical laboratory medicine to national professional societies, which are full members of IFCC, to the diagnostic industry and to governmental and non-governmental organisations in order to serve the public interest in health care. FESCC mission is to support and promote laboratory medicine in Europe, to aid communication between IFCC and the National Societies, to promote education and quality, and to encourage young European scientist to take an active role and part in the above described activities The major items of FESCC are described in the strategic plan of 2003'2005 and contain the progress of clinical chemistry and laboratory medicine in science and in the profession, promotion of education and training, and organisation and total quality management of laboratory medicine accreditation. There is a great interest in the profession harmonisation and regulation by law in the European Union and there is also a growing effort in cooperation of the European Societies in Laboratory Medicine.
Efforts are going on for organizations of international courses and also for exchanges between European subregions. The key strategic issues are: identifying specific European problems, identifying specific sub regional areas of co-operation, improving training and increasing co-operation with other organisations.
FESCC reorganises Europe in different European sub regions. The major group is the European Union (EU) organized in an autonomous FESCC subgroup EC4 (European Communities Confederation of Clinical Chemistry and Laboratory Medicine) who promote harmonization of practice and scientific quality across the EU countries. The political entity of the European Union and the regulations and legislation coming forth from that, makes EC4 a valuable organisation of clinical chemistry in the region. The cooperation is also important in view of the extension of the European Union. A large number of countries are candidate members. Harmonization of the profession via registration will prove to be important. There exists a close co-operation between FESCC and EC4 towards other international bodies. FESCC and EC4 have a joint representative in the European co-operation for accreditation. Accreditation is a very important issue having a major impact on the functioning of laboratories. FESCC represent IFCC by the EC4-FESCC working group on accreditation in the relevant CEN working groups. Also towards the European Diagnostic Manufacturers Association (EDMA) FESCC and EC4 have the same strategy. The co-operation with industry becomes more and more important particularly with respect to the harmonization of laboratory data and the impact of the In Vitro Diagnostics Directive. FESCC recognize the importance of influence on and control from the profession on the developments regarding reference systems. The desired analytical performance of instruments and methods should be able to adapt undesired performance of instruments. FESCC has contacts with the European Commission (EC) and plays an important role with EDMA in order to come to one voice on the European theatre. FESCC continues its efforts to work together with WHO to realize former stated items.
Also the co-operation with the organisation of the biopathologists section of UEMS needs joint attention.
We have further the subgroups from the Balkan, the Baltic, North Europe with the Scandinavian countries, East Europe with Russia, Ukraine and Belarus, and finally the Alps-Adrian group. Training and education in laboratory medicine is a major task for FESCC. Progress in Laboratory science is largely the result of contributions by scientists with an adequate education and specialisation in the field. Clinical laboratory science has developed on a broad front throughout the European Community, resulting in significant differences in what constitutes a national clinical chemistry service in each state. One of the main task of education in laboratory medicine involves bridging the gap between rapidly developing laboratory science and technology and the growing knowledge on characteristics of disease. To ensure freedom of movement in the European Union for employment there is a need for harmonization of training. National diplomas are not automatically recognised, therefore common standards of competence and national diplomas which meet these criteria were developed and accepted by the National Societies of Clinical Chemistry and Laboratory Medicine and described in the EC4 syllabus for post graduate training in clinical chemistry. Registration as »European clinical chemist« is one way for harmonisation of the profession. Other very fundamental questions about the essence of our profession, however, need our attention. The »raison d'õtre« (reason of existence) of Laboratory Medicine is approached and judged on the basis of the impact of the flow of laboratory data on the clinical data. The complexity of the healthcare environment and the ever-expanding array of available laboratory tests will inevitably increase the need for greater integration between clinical information and laboratory data. Our impact on the medical environment of the future will not only to maintain the highest quality of data generated in our labs, but rather to maximize the influence of laboratory results on patient management. It is difficult to predict the future, but that does not mean that we are not in the possibility to prepare for it. Taking all the comments above into account you will feel the need to have a house for Clinical Chemistry in Europe where we can meet and discuss our common interests and differences in order to further develop our basic mission: »Serving Clinical Care and Laboratory Medicine in Europe for the benefit of our patients«. Therefore we started discussions with the Charles University of Prague and signed an agreement on the »Interuniversity Co-operation The Charles University Prague and FESCC« Its primary aims are to advance science and medicine in general, to hold scientific and educational events, to co-ordinate activities in the field in Europe and to seek to further European co-operation and harmonisation. In order to encourage and develop the scientific and cultural co-operation of both institutions educational actions and scientific events are organised. Special attention should be given to the organisation of post graduate courses. The house in Prague »Education and training centre for Laboratory Medicine ' FESCC ' The Carolinum Charles University of Prague« organises a first discussion forum on postgraduate education of clinical chemistry in Europe and the centre is also open for the promotion of the profession. (2) . For the first time there will be an internationally recognized standard designed especially for the accreditation of medical labs. The document takes into account the special requirements imposed by the medical environment and by the essential contribution of the medical laboratory service to patient care. Very important, it recognizes that medical laboratories must provide not only testing of patient samples, but also advisory, interpretative and educational services. A further document, still in draft form (ISO/DIS 15190) deals with safety management for medical laboratories Also towards the European Diagnostic Manufacturers Association (EDMA) FESCC and EC4 have a common strategy. The cooperation with the industry becomes more and more important particularly with respect to the harmonization of laboratory data and the impact of the Vitro Diagnostic Directive. FESCC and EC4 recognize the importance of influence on and control from the profession on the developments regarding reference systems. The desired analytical performance of instruments and methods should be defined by the profession. The profession should also be able to adapt undesired performance of instruments.
Accreditation in the EU: FESCC Survey
The freedom of movement of people and goods within the European Union has a large impact for the member states. Particularly within health care it is important to harmonize the quality of the profession and practice, so that health care is offered at a comparable level. The importance of harmonization also regards clinical chemistry. This was recognized by the IFCC related National Societies of clinical chemistry in EU countries. The common political reality led to the institution of the European Communities Confederation of Clinical Chemistry (EC4). Diagnosis and therapy are now the core business of health care. Medical laboratories play an essential role in this. The broad spectrum of medical laboratory investigations make consultancy of medical laboratory specialists even more important. The quality of both professionals and laboratories, as well as continuity of laboratory data within and between laboratories are of the most importance. The main goal of FESCC is quality trough harmonization of our profession in Europe.
The instalment of the EC4 Register of the European Clinical Chemists is a large step forward towards the attainment of the first level, harmonization of the profession. In most EU countries National Registers exists and in some others several registers exist, depending on the academic background and education. Colleagues from all relevant academic background, scientific as well as medicine, may and do apply. The EU registration is based on the assignment of equivalence of standards to national register
Accreditation and postgraduate training in European countries
At the present time, there is no detailed knowledge of professional education of specialist in laboratory medicine in the non-EU countries. As harmonization of quality assessment and accreditation procedures are listed among the main goals of FESCC, according to its 1999 ' 2003 strategic plan, it is acceptable that many other countries are willing to adapt their system of professional education to the FESCC EC4 model. By example on this basis, it might be interesting to implement a parallel register for European Clinical Chemist belonging to non EU members.
FESCC launched a survey in July 1998 to gather information on postgraduate education and on accreditation in clinical chemistry and laboratory medicine. The major data of the survey are published (3, 4) . The questionnaire was sent July 1998 to all presidents of the FESCC related member societies. The most important questions are: which graduate training can lead to a postgraduate training in clinical chemistry and is training in clinical chemistry a postgraduate one. Does training in clinical chemistry (clinical biology) match the European syllabus. The main data considered as a first conclusion provided on accreditation show that the number of accredited laboratories was low in the EU countries and even lower in the non-EU members. The situation is changing fast and the accredited sites is expected to increase rapidly in the next years. The ISO-Document 15 189 can gather a large consensus from all national European bodies involved in accreditation. There was also a hope that professionals should be vigilant and try to maintain the costs to a reasonable level. The heterogeneity of the data on post-graduate training in clinical chemistry indicates that a great effort will be needed before harmonisation is reached. The data on clinical chemistry training in the non-EU countries show some similarities with the data from the EU countries. The answers on the clinical chemistry curriculum and examinations were quite heterogeneous, a common trend indicated a mixed practical and theoretical training, with similarity in the treated topics, such as general analytical principles and procedures, external and internal quality control, method comparison and laboratory management. Large differences exist in the disciplines of medical laboratories which are headed, their managerial tasks, the position within the medical staff of hospitals, the advisory task that are practised and the managerial part of the post-graduate curriculum in clinical chemistry. Despite these differences the profession has similar interdisciplinary character in all European countries and ask for harmonization of the profession.
The Future of Clinical Chemistry in Europe
European regulations as a basis for total quality management I was lucky to be associated to an institution with a history of 900 years, more than 8 centuries. The old St John Hospital is situatd at the centre of Bruges and the first ward was built in 1150. Organized laboratory activities started around 1915, a laboratory of micro-biology and clinical chemistry was established by a chemist-bacteriologist. A new science was born laboratory medicine. This contribution was diagnostically and therapeutically very important. The knowledge of biological parameters has strongly influenced the specialisation in medicine. Over the past 75 years the laboratory analyses have been extremely valuable, especially in the field of preventive medicine. The massive growth of biological possibilities resulted however last years in over consumption, irresponsible requests and finally in a certain devaluation of our profession. The industrial revolution was a first reason for integration. Automatization, robotization, intra and internet systems ask for European standardization, guarantee of quality and accreditation leading to ISO and CEN standards. The cultural exchange between countries and the world economy resulted in unification of Europe. All this raises the actual questions about total quality management in Europe. In view of the new challenges and the implications of them on socio-economical, financial and medical level, the former mentioned questioning towards the European community is quite normal. The application and the integration of the clinical biological parameters go trough an enormous development and some examples are obvious and belongs to the strategic plans of FESCC over the period from 2004 ' 2007.
Evidence based medicine (EBM) has been driven by the need to cope with information overload, by cost control and by a public impatience for the best in diagnostics and treatment. Laboratory professionals must direct more effort to demonstration the impact of laboratory tests on a greater variety of clinical outcomes. There is a poverty of good primary studies of test evaluations. Total quality management is focused on the pre-analytical steps from the patient to the sample. At the present time those are the most important limiting factors of the quality of laboratory results. International standards play an important role in establishing quality systems. A great number has been created by ISO and CEN for medical laboratories. Most standards are suggested by industry or national and international organisations. Individuals rarely influence the contents. The suggested standard (ISO 15 189) on quality specifications in laboratory medicine is an exception. FESCC request special attention to increase efforts for continuous training and education. Molecular diagnostic tools are becoming smaller and the impact on the medical discipline is growing rapidly. Objective evaluation of data in screening of disease and guidelines and algorithms need special attention. One of the major forces in information technology (IT) which provides a new economic and business model for laboratory medicine industry based on an integrated vertical meta-network, summarized in »total laboratory solution (TLS).
Before ending I like to refer to major items of FESCC strategic plan actions for the near future
• Cooperation with and between European FESCC subgroups
• Promotion of a common platform for all disciplines of laboratory medicine Chemistry and Laboratory Medicine), aktuelne oblasti glavnih aktivnosti i klju~ne pravci razvoja u Evropi. Misija FESCC-a je da potpomogne i promovi{e klini~ku hemiju u Evropi, da poma`e u saradnji sa IFCC-om (Intenational Federation of Clinical Chemistry), da razvija edukaciju i kvalitet u disciplini i da ohrabri mlade nau~nike da aktivno sudeluju u ovim aktivnostima. Totalni sistem kvaliteta u medicinskim i klini~kim laboratorijama i akreditacija laboratorija postaje sve ~e{}a i va`nija. Laboratorijski specijalisti se danas suo~avaju sa novim na~inom razmi{ljanja u odnosu na rukovo|enje i svakodnevnu praksu u laboratorijama. Naro~ito u Evropskoj Zajednici (EU), harmonizacija kriterijuma kvaliteta je od posebne va`nosti. Sloboda kretanja ljudi i dobara unutar EU ima zna~ajan uticaj na svaku ~lanicu posebno. FESCC je obavio istra`ivanja u Evropi koja se odnose na akreditaciju medicinskih laboratorija i obu~avanje sa posebnom pa`njom koja se odnosi na poslediplomsko usavr{avanje u okviru profesije. Drugo istra`ivanje je obuhvatilo vi{e informacija koje se odnose na polo`aj specijalista klini~ke hemije u Evropi. Harmonizacija profesije je jedan od izazova za evropske specijaliste klini~ke hemije kao i za sam FESCC. Ovde se opisuju i faktori koji }e biti presudni za laboratorijsku medicinu u budu}nosti.
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